Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Majella Doyle

Showing results (71-80 of 95) with videos related to

Pageof 10
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|October 17, 2018
Systemic Therapy for Combined Hepatocellular-Cholangiocarcinoma: A Single-Institution ExperienceNikolaos A Trikalinos, Amy Zhou, Maria B Majella Doyle, et al.
Journal of Surgical Education|June 1, 2024
Cross-fellowship Inter-institutional Exchange: Answering the Call for Hepatopancreatobiliary Training StandardizationAngela Lee Hill, Darren R Cullinan, Roheena Z Panni, et al.
Frontiers in Oncology|August 22, 2024
Arterial hypoperfusion as a negative predictive marker for primary hepatic malignancies treated with Y-90 glass microsphere transarterial radioembolizationBita Kalaghchi, Semra Ince, Justin Barnes, et al.
Journal of the American College of Surgeons|October 24, 2017
Surgeon Variation in Intraoperative Supply Cost for Pancreaticoduodenectomy: Is Intraoperative Supply Cost Associated with Outcomes?David G Brauer, Kerri A Ohman, David P Jaques, et al.
Journal of the American College of Surgeons|March 3, 2015
Surgical treatment of hepatocellular carcinoma in North America: can hepatic resection still be justified?William C Chapman, Goran Klintmalm, Alan Hemming, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|July 11, 2009
The effect of mesh reinforcement of a stapled transection line on the rate of pancreatic occlusion failure after distal pancreatectomy: review of a single institution's experienceFabian Mc Johnston, Antonino Cavataio, Steven M Strasberg, et al.
Surgery|March 6, 2026
It's Showtime! Two interventions reduce operating room turnover time by 20% in an academic medical centerBrendan P Lovasik, Meranda D Scherer, Danielle Theodorou, et al.
Current Problems in Surgery|December 12, 2018
Hepatocellular carcinoma: Where are we in 2018?William C Chapman, Kevin M Korenblat, Kathryn J Fowler, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 1, 2026
Achieving zero waitlist mortality for children on the pediatric liver transplant waitlistElizabeth King, Carolyn Reuland, Bhargava Mullapudi, et al.
Clinical Transplantation|August 4, 2017
The influence of functional warm ischemia time on DCD liver transplant recipients' outcomesJessica C Coffey, Kerollos N Wanis, Diethard Monbaliu, et al.
Pageof 10

Showing results (71-80 of 95) with videos related to

Sort By:
Pageof 10
Journal of the National Comprehensive Cancer Network : JNCCN|October 17, 2018
Systemic Therapy for Combined Hepatocellular-Cholangiocarcinoma: A Single-Institution ExperienceNikolaos A Trikalinos, Amy Zhou, Maria B Majella Doyle, et al.
Journal of Surgical Education|June 1, 2024
Cross-fellowship Inter-institutional Exchange: Answering the Call for Hepatopancreatobiliary Training StandardizationAngela Lee Hill, Darren R Cullinan, Roheena Z Panni, et al.
Frontiers in Oncology|August 22, 2024
Arterial hypoperfusion as a negative predictive marker for primary hepatic malignancies treated with Y-90 glass microsphere transarterial radioembolizationBita Kalaghchi, Semra Ince, Justin Barnes, et al.
Journal of the American College of Surgeons|October 24, 2017
Surgeon Variation in Intraoperative Supply Cost for Pancreaticoduodenectomy: Is Intraoperative Supply Cost Associated with Outcomes?David G Brauer, Kerri A Ohman, David P Jaques, et al.
Journal of the American College of Surgeons|March 3, 2015
Surgical treatment of hepatocellular carcinoma in North America: can hepatic resection still be justified?William C Chapman, Goran Klintmalm, Alan Hemming, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|July 11, 2009
The effect of mesh reinforcement of a stapled transection line on the rate of pancreatic occlusion failure after distal pancreatectomy: review of a single institution's experienceFabian Mc Johnston, Antonino Cavataio, Steven M Strasberg, et al.
Surgery|March 6, 2026
It's Showtime! Two interventions reduce operating room turnover time by 20% in an academic medical centerBrendan P Lovasik, Meranda D Scherer, Danielle Theodorou, et al.
Current Problems in Surgery|December 12, 2018
Hepatocellular carcinoma: Where are we in 2018?William C Chapman, Kevin M Korenblat, Kathryn J Fowler, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 1, 2026
Achieving zero waitlist mortality for children on the pediatric liver transplant waitlistElizabeth King, Carolyn Reuland, Bhargava Mullapudi, et al.
Clinical Transplantation|August 4, 2017
The influence of functional warm ischemia time on DCD liver transplant recipients' outcomesJessica C Coffey, Kerollos N Wanis, Diethard Monbaliu, et al.
Pageof 10